1. Home
  2. SRDX vs PANL Comparison

SRDX vs PANL Comparison

Compare SRDX & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • PANL
  • Stock Information
  • Founded
  • SRDX 1979
  • PANL 1996
  • Country
  • SRDX United States
  • PANL United States
  • Employees
  • SRDX N/A
  • PANL N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • PANL Marine Transportation
  • Sector
  • SRDX Health Care
  • PANL Consumer Discretionary
  • Exchange
  • SRDX Nasdaq
  • PANL Nasdaq
  • Market Cap
  • SRDX 402.2M
  • PANL 414.5M
  • IPO Year
  • SRDX 1998
  • PANL N/A
  • Fundamental
  • Price
  • SRDX $41.40
  • PANL $6.50
  • Analyst Decision
  • SRDX Buy
  • PANL Strong Buy
  • Analyst Count
  • SRDX 3
  • PANL 1
  • Target Price
  • SRDX $43.00
  • PANL $9.00
  • AVG Volume (30 Days)
  • SRDX 252.6K
  • PANL 225.7K
  • Earning Date
  • SRDX 11-05-2025
  • PANL 11-06-2025
  • Dividend Yield
  • SRDX N/A
  • PANL 3.10%
  • EPS Growth
  • SRDX N/A
  • PANL N/A
  • EPS
  • SRDX N/A
  • PANL 0.27
  • Revenue
  • SRDX $120,801,000.00
  • PANL $595,335,937.00
  • Revenue This Year
  • SRDX N/A
  • PANL $13.00
  • Revenue Next Year
  • SRDX $3.38
  • PANL N/A
  • P/E Ratio
  • SRDX N/A
  • PANL $24.12
  • Revenue Growth
  • SRDX N/A
  • PANL 14.22
  • 52 Week Low
  • SRDX $25.87
  • PANL $3.93
  • 52 Week High
  • SRDX $41.67
  • PANL $6.80
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 83.94
  • PANL 78.21
  • Support Level
  • SRDX $26.00
  • PANL $4.71
  • Resistance Level
  • SRDX $28.67
  • PANL $6.54
  • Average True Range (ATR)
  • SRDX 0.94
  • PANL 0.23
  • MACD
  • SRDX 1.54
  • PANL 0.20
  • Stochastic Oscillator
  • SRDX 98.23
  • PANL 95.15

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: